Fig 1.
PRISMA flowchart, showing the search and study selection strategy.
Table 1.
Global, regional and sub-regional pooled T-seroprevalence (results from 250 studies performed in 71 countries).
Fig 2.
Forest plot of the T-seroprevalence by WHO-region and globally.
ES: estimated T-seroprevalence for WHO-regions and individual countries.
Fig 3.
T-seroprevalence (%) in humans worldwide. Maps drawn by the authors; they are original and have not been published previously.
Table 2.
The global T-seroprevalence and number of seropositive people in the general population in the WHO regions.
Table 3.
T-seroprevalence in the general population based on sub-groups according to different socio-demographic and geographic parameters, calculated using a random effects model (REM).
Fig 4.
Meta-regression analysis showing a non-statistically significant upward trend in the rates of T-seroprevalence in humans with increasing contamination of soil with Toxocara eggs.
Table 4.
Risk factors associated with seropositivity to Toxocara in the general population in the world.